As of Mar 21
| +0.65 / +6.70%|
The 1 analysts offering 12-month price forecasts for Fennec Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 22.00 and a low estimate of 22.00. The median estimate represents a +112.56% increase from the last price of 10.35.
The current consensus among 1 polled investment analysts is to Buy stock in Fennec Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.